Status quo and prevention of overtreatment in cervical diseases

The objective of this paper was to review the diagnosis and treatment of cervical diseases. Often, due to improper judgment of interventional indications for cervical lesions, overtreatment to various degrees takes place, influencing patients' health and lives. This review analyzes the expression, causes and negative aspects of overtreatment of cervical lesions, and discusses the available therapeutic methods for cervical lesions, to remind gynecologists to master the interventional indications for proper treatment and avoid overtreatment, so as to achieve normalization and individualization in treating gynecologic diseases.

Cervical Diseases; Overtreatment; Prevention

[1] Petry K.U.: “Management options for cervical intraepithelial neoplasia”. Best. Pract. Res. Clin. Obstet. Gynaecol., 2011, 25, 641.

[2] Carcopino X., Muszynski C., Mergui J.L., Gondry J., Boubli L.: “Should CIN 2 and 3 be treated the same way?”. Gynecol. Obstet. Fertil., 2011, 39, 94.

[3] McKeage K., Romanowski B.: “AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix): a review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic HPV types”. Drugs, 2011, 71, 465.

[4] Perlman S.E., Lubianca J.N., Kahn J.A.: “Characteristics of a group of adolescents undergoing loop electrical excision procedure (LEEP)”. J. Pediatr. Adolesc. Gynecol., 2003, 16, 15.

[5] Sheeder J., Stevens-Simon C., Lezotte D., Glazner J., Scott S.: “Cervicitis: to treat or not to treat? The role of patient preferences and decision analysis”. J. Adolesc. Health., 2006, 39, 887.

[6] Elit L., Levine M.N., Julian J.A., Julian J.A., Sellors J.W., Lytwyn A. et al.: “Expectant management versus immediate treatment for low-grade cervical intraepithelial neoplasia: a randomized trial in Canada and Brazil”. Cancer, 2011, 117, 1438.

[7] Le Jie: “Obstetrics and Gynaecology”. People’s Medical Publishing House, Beijing, 2005, version 6 (in Chinese).

[8] Liao Qinping, Liu Zhaohui, Zhang Dai: “Strategies for diagnosis and treatment of cervical infectious diseases in China”. Chinese Military Medical Press, Beijing, 2009, version 1.

[9] Luska M.J., Konecony P.: “Cervicitis: a Review”. Curr. Opin. Infect. Diseas., 2008, 1, 49.

[10] Misson D.R., Abdalla D.R., Borges A.M., Shimba D.S., Adad S.J., Michelin M.A. et al.: “Cytokine serum levels in patients with cervical intraepithelial neoplasia grade II-III treated with intralesional interferon-α 2b”. Tumori, 2011, 97, 578.

[11] Chen R.J., Chang D.Y., Yen M.L., Chow S.N., Huang S.C.: “Loop electrosurgical excision procedure for conization of the uterine cervix”. J. Formos Med. Assoc., 1994, 93, 196.

[12] Xiong N.H.: “Clinical and experimental studies on sanpin therapy for chronic cervical diseases”. Zhongguo Zhong Xi Yi Jie He Za Zhi, 1993, 13, 10 (in Chinese).

[13] Le Jie: “Obstetrics and Gynaecology”. the People’s Medical Publishing House, Beijing, 2008, version 7.

[14] Marrazzo J.M., Martin D.H.: “Management of women with cervicitis”. Clin. Infect. Dis., 2007, 44, 102.

[15] Siebers A.G., Massuger L.F., Bulten J.: “Referral compliance, outcome and predictors of CIN after repeated borderline cervical smears in the Netherlands”. J. Cytopathology, 2007, 18, 96.

[16] Verguts J., Bronselaer B., Donders G., Arbyn M., Van Eldere J., Drijkonigen M., Poppe V.: “Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation”. BJOG, 2006, 113, 1303.

[17] Bansal N., Wright J.D., Cohen C.J., Herzog T.J.: “Natural history of established low-grade cervical intraepithelial (CIN 1) lesions”. Anticancer Res., 2008, 28, 1763.

[18] Sally C., Sabaratnam A., Kevin H.: “Management of cervical intraepithelial neoplasia (CIN)”. Oxford Handbook of Obstetrics Gynaecology, 2008, 399.

[19] Prétet J.L., Jacquard A.C., Saunier M., Clavel C., Dachez R., Gondry J. et al.: “Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH Study”. Int. J. Cancer, 2008, 122, 424.

[20] Bollmann M., Várnai A.D., Griefingholt H., Bánkfalvi A., Callenberg H., Speich N. et al.: “Predicting treatment outcome in cervical diseases using liquid-based cytology, dynamic HPV genotyping and DNA cytometry”. Anticancer Res., 2006, 26, 1439.

[21] Scardamaglia P., Carraro C., Mancino P., Stentella P.: “Effectiveness of the treatment with beta-glucan in the HPV-CIN 1 lesions”. Minerva Ginecol., 2010, 62, 389.

[22] Ayhan A., Boynukalin F.K., Guven S., Dogan N.U., Esinler I., Usubutun A.: “Repeat LEEP conization in patients with cervical intraepithelial neoplasia grade 3 and positive ectocervical margins”. J. Gynaecol. Obstet., 2009, 105, 14.

[23] Kjellberg L,. Tavelin B.: “See and treat’ regime by LEEP conisation is a safe and time saving procedure among women with cytological high-grade squamous intraepithelial lesion”. Acta Obstet. Gynecol. Scand., 2007, 6, 1140.

[24] Mooring C.E., O’Rourke P.K., Kimble R.M.: “Large loop excision of transformation zone procedures used in the management of cytological abnormalities of the cervix”. Aust. N.Z.J. Obstet. Gynaecol., 2011, 51, 109.

[25] Park J.Y., Lee S.M., Yoo C.W., Kang S., Park S.Y., Seo S.S.: “Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer”. Gynecol. Oncol., 2007, 107, 39.

[26] Janthanaphan M., Wootipoom V., Tangsinmunkong K., Liabsuetrakul T.: “Comparison of success rate and complications of contour-loop excision of the transformation zone (C-LETZ) with cold knife conization (CKC) in high grade lesion (HGL) from colposcopic impression”. J. Med. Assoc. Thai., 2009, 92, 1573.

[27] Boyadzhieva M., Atanassova I., Dimitrova V., Zaharieva S., Tankova T., Grozeva G. et al.: “Our and foreign experience in surgical treatment of CIN III-cold knife conisation versus LLETZ”. Akush Ginekol. (Sofiia), 2010, 49, 9.

[28] Jagannathan J., Sherman J.H., Szabo T., Shaffrey C.I., Jane J.A.: “The posterior cervical foraminotomy in the treatment of cervical disc osteophyte disease: a single-surgeon experience with a minimum of 5 years’ clinical and radiographic follow-up”. Neurosurg. Spine, 2009, 10, 347.

[29] Korinth M.C.: “Treatment of cervical degenerative disc disease -current status and trends”. Zentralbl. Neurochir., 2008, 69, 113.

[30] Baloglu A., Uysal D., Bezircioglu I., Bicer M., Inci A.: “Residual and recurrent disease rates following LEEP treatment in highgrade cervical intraepithelial lesions”. Arch. Gynecol. Obstet., 2009, 282, 69.